Selection of a CDMO can lead to successful clinical trials, approved NDAs, and product approvals. LBG’s Georgia Sloboda, Managing Director, CMC, and Patrick Falvey, Principal Consultant, who have been invited …
The Cell & Gene Meeting on the Mesa is taking place in Carlsbad, California, on October 11 – 13. Joseph Rininger, Ph.D., Managing Director; Jim Beltzer, Ph.D., Principal Consultant; and …
LBG’s Frank Orlowski, Director, Business Development, has been invited to be a keynote speaker at the Global Bio & Pharma Plaza (GBPP 2022)—one of the biggest pharmaceutical and biopharmaceutical industry …
Co-authored by Thijs Beuming, Ph.D., Principal Consultant, “Are Deep Learning Structural Models Sufficiently Accurate for Free-Energy Calculations? Application of FEP+ to AlphaFold2-Predicted Structures,” was recently published in the Journal of …
Robert Casillas, Ph.D., Managing Director, Discovery, Nonclinical, and Animal Health Consulting, has been invited to attend and speak at the 73rd Annual Toxicology Roundtable in Ruidoso, New Mexico, on October …
